Hilde Demuynck

Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis

Johan Maertens, Jan Verhaegen, Hilde Demuynck et al. · Journal of Clinical Microbiology · 1999 · 376 citations · Full text

Life Sciences, Hematology, Microbiology +14

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

Enric Carreras, Hartmut Bertz, William Arcese et al. · PubMed · 1998 · 345 citations

Medicine, Hematology, Internal Medicine +15

Peripheral blood lymphocyte subset shifts in patients with untreated hematological tumors: Evidence for systemic activation of the T cell compartment

Ludwig E. Van den Hove, Peter Vandenberghe, Stefaan W. Van Gool et al. · Leukemia Research · 1998 · 73 citations

Medicine, Hematology, Immunology +14

Growth Inhibitory Effects of Transforming Growth Factor-β1 in vivo

Agnieszka Migdalska, Graham Molineux, Hilde Demuynck et al. · Growth Factors · 1991 · 71 citations

Life Sciences, Cell Biology, Developmental Biology +14

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 47 citations

Medicine, Oncology, Pharmacotherapy +12